Biotec Pharmacon is a scientific-based industrial company that are developing, producing and marketing immune modulating beta-glucans and cold adapted enzymes, including special formulated products derived from these ingredients. The Company operates in two business areas managed by two separate operating units.


The shares of Biotec Pharmacon ASA are listed on the Oslo Stock Exchange. The listing took place on 4 November 2005. The ticker symbol for Biotec Pharmacon is BIOTEC.

Share registrar
Postboks 1600 Sentrum | NO-0021 Oslo | Norway
For <strong>Investor Relations</strong> inquiries, please contact our CFO
Børge Sørvoll,
P.O. Box 6463,
NO-9294 Tromsø